As COVID deaths and hospital admissions remain stubbornly high, there are calls to expand eligibility for antivirals, which can prevent serious illness. But not everyone agrees - some experts argue that authorities should continue to focus on vulnerable groups, and make sure they get access to the treatment as early as possible.